gilead sciences inc.

GILD

Close Chg Chg %
73.69 -0.43 -0.58%

Closed Market

73.26

-0.43 (0.58%)

Volume: 6.94M

Last Updated:

Mar 18, 2024, 4:00 PM EDT

Healthcare

Inside the race for a COVID-19 treatment pill

Pfizer and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG are racing to produce the first antiviral pill that people could take at early signs of the illness. Their shared goal: filling a key treatment hole by helping people recently-infected with coronavirus to avoid becoming seriously ill and needing hospitalization.

Markets

COVID-19 vaccine start-up files for IPO

The biotech startup behind the COVID-fox19 vaccine jointly developed by AstraZeneca PLC and the University of Oxford filed Friday with U.S. regulators for a public share offering. Vaccitech PLC said in a securities filing it plans to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, hepatitis B and human papillomavirus.